"A Reuters article published in February 2011 characterised the laboratory erected at the [Sierra Leonean] government hospital in Kenema as an outpost of the 'war on terror,' fuelled by $40 million in
biodefence dollars."
It was, he concludes, simply a case of a dominant ideology ('a fire-power obsession') which made serious consideration of
biodefence impossible.
Cangene develops and markets speciality therapeutics mainly used in the
biodefence industry.
This section aims to review the use of microarrays and next-generation sequencing in relation to defining the host response against
biodefence agents, vaccines, and therapies.
According to Plascon, the paint is formulated using its own
biodefence silver technology enhancing its capacity to "protect against harmful bacteria such as E.coli and Staphylococcus aureus and does not wash or wear off during the lifetime of the paint."
1 May 2012 - GE Capital, Healthcare Financial Services said on Monday it had acted as the sole lender and administrative agent on USD7.5m (EUR5.7m) in senior secured credit facilities for US
biodefence company PharmAthene (NYSEAMEX:PIP).
The division's main short-term strategic goals are the continued delivery of smallpox vaccine Imvamune under the contract with the US government, while also securing new Imvamune orders and developing late-stage vaccine candidates for infectious diseases beyond
biodefence, supported by partnerships and/or acquisitions.
The company's pipeline is focused in the three areas; cancer,
biodefence and infectious diseases, and includes seven development programmes.
Some of the people who have long warned about botulinum as a bioterror agent, and their colleagues, are high-level advisors on
biodefence in the US government and on the Graham-Talent Commission.
The rapid development time, high sensitivity, ease-of-use and low costs of the company's tests meet the needs of many markets, including environmental, life science research, in vitro diagnostics,
biodefence testing, and food and beverage testing.
The 1995 sarin gas attack in the Tokyo subway system by the terrorist group Aum Shinrikyo and the 2001 mailing of weaponized anthrax spores through the US postal system sensitized policymakers in industrialized countries to the vulnerability of their populations to chemical and bio-weapons, and more important, brought about a convergence of national
biodefence programmes with existing disease control activities.
The company's business strategy is focused in three areas:
biodefence, cancer and infectious diseases.
The Company is largely focused on infectious disease and
biodefence targets.
